We are live on ! Find out more
WS

Wedbush Securities Portfolio holdings

AUM $3.43B
1-Year Est. Return 24.13%
This Fund
S&P 500
This Quarter Est. Return
+3.61%
1 Year Est. Return
+24.13%
3 Year Est. Return
+79.76%
5 Year Est. Return
+94.69%
10 Year Est. Return
+325.94%
AUM
$671M
AUM Growth
+$60.4M
Cap. Flow
+$46.4M
Cap. Flow %
6.91%
Top 10 Hldgs %
18.26%
Holding
913
New
123
Increased
382
Reduced
229
Closed
79

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$2.42M
2
TRTN
Triton International Limited
TRTN
+$1.4M
3
GE icon
GE Aerospace
GE
+$919K
4
ABBV icon
AbbVie
ABBV
+$883K
5
INTC icon
Intel
INTC
+$865K

Top Sells

Rank Stock Value
1
TAL
TAL INTERNATIONAL GROUP, INC.
TAL
+$1.44M
2
SHV icon
iShares 0-1 Year Treasury Bond ETF
SHV
+$1.06M
3
UFI icon
UNIFI
UFI
+$876K
4
CVS icon
CVS Health
CVS
+$863K
5
NRIM icon
Northrim BanCorp
NRIM
+$813K

Sector Composition

Rank Sector Weight
1 Real Estate 10.08%
2 Financials 9.97%
3 Healthcare 9.71%
4 Consumer Discretionary 9.13%
5 Industrials 8.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TTPH
776
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$40K 0.01%
+525
New +$42.1K
TOVX icon
777
Theriva Biologics
TOVX
$10.2M
$38K 0.01%
3
– –
PWE
778
DELISTED
Penn West Energy Petroleum Ltd
PWE
$37K 0.01%
20,675
-21,325
-51% -$33.1K
ENLV icon
779
Enlivex Ltd
ENLV
$70.7M
$36K 0.01%
35
+7
+25% +$7.11K
EVRI
780
DELISTED
Everi Holdings
EVRI
$35K 0.01%
14,000
– –
IPI icon
781
Intrepid Potash
IPI
$460M
$35K 0.01%
3,113
+1,650
+113% +$21.6K
CYTO
782
DELISTED
Altamira Therapeutics Ltd
CYTO
– –
0
– –
CHMA
783
DELISTED
Chiasma, Inc. Common Stock
CHMA
$29K ﹤0.01%
10,000
– –
WINT
784
DELISTED
Windtree Therapeutics Inc
WINT
$28K ﹤0.01%
10,784
– –
GGB icon
785
Gerdau
GGB
$9.44B
$27K ﹤0.01%
12,637
+4
+0% +$8
ARNA
786
DELISTED
Arena Pharmaceuticals Inc
ARNA
$27K ﹤0.01%
1,559
+100
+7% +$1.66K
ERN
787
DELISTED
Erin Energy Corp
ERN
$26K ﹤0.01%
11,217
– –
GYRE icon
788
Gyre Therapeutics
GYRE
$662M
$25K ﹤0.01%
187
+67
+56% +$10.1K
UTSI icon
789
UTStarcom
UTSI
$22.7M
$25K ﹤0.01%
3,012
-2,772
-48% -$22.1K
FCRE
790
DELISTED
FC Global Realty Incorporated Common Stock
FCRE
$23K ﹤0.01%
18,001
+14,401
+400% +$17.4K
HTM
791
DELISTED
U.S. Geothermal Inc.
HTM
$21K ﹤0.01%
4,867
– –
IMMP
792
Immutep
IMMP
$56.7M
$18K ﹤0.01%
6,000
– –
BIOL
793
DELISTED
Biolase, Inc.
BIOL
$18K ﹤0.01%
1
– –
CVEO icon
794
Civeo
CVEO
$379M
$17K ﹤0.01%
1,250
+417
+50% +$6.8K
DARE icon
795
Dare Bioscience
DARE
$19.2M
$17K ﹤0.01%
133
– –
PLX icon
796
Protalix BioTherapeutics
PLX
$191M
$17K ﹤0.01%
3,000
+1,200
+67% +$7.48K
CIE
797
DELISTED
Cobalt International Energy, Inc
CIE
$13K ﹤0.01%
720
-200
-22% -$3.71K
SDPI
798
DELISTED
Superior Drilling Products Inc.
SDPI
$12K ﹤0.01%
+13,000
New +$17K
KALV
799
DELISTED
KalVista Pharmaceuticals
KALV
$10K ﹤0.01%
1,550
-620
-29% -$4.67K
SSKN
800
DELISTED
Strata Skin Sciences
SSKN
$10K ﹤0.01%
362
– –
30 31
32
33 34

Similar funds

CCM
Check Capital Management Costa Mesa, California $3.44B AUM 9.15% 1-Year Est. Return
SI
Sprott Inc Toronto, Ontario, Canada $3.44B AUM 125.26% 1-Year Est. Return
CIA
Caledonia Investments (Australia) Sydney NSW, Australia $3.44B AUM 20.03% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
PWP
Perfromance Wealth Partners Hinsdale, Illinois $3.45B AUM 29.14% 1-Year Est. Return
RBA
Richard Bernstein Advisors New York $3.45B AUM 16.24% 1-Year Est. Return
PCM
PAR Capital Management Boston, Massachusetts $3.45B AUM 28.5% 1-Year Est. Return
LNC
Lincoln National Corp Radnor, Pennsylvania $3.45B AUM 12.55% 1-Year Est. Return

Wedbush Securities's Q3 2016 Portfolio in Review

As of Q3 2016, Wedbush Securities held 913 positions worth $671M, up 9.9% from $611M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Wedbush Securities deployed $46.4M of net new capital in Q3 2016, opening 123 new positions and adding to 382 existing holdings. Its largest new stake was Triton International Limited: 92,729 shares worth $1.22M.

By sector, the portfolio is most concentrated in Real Estate at 10% of assets, down from 11% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares 0-1 Year Treasury Bond ETF, an estimated $1.06M trimmed.

  • Wedbush Securities's largest Q3 2016 buy was Triton International Limited: 92,729 shares worth $1.22M.
  • Wedbush Securities added most to Bristol-Myers Squibb in Q3 2016, an estimated $2.42M increase.
  • Wedbush Securities's biggest Q3 2016 reduction was iShares 0-1 Year Treasury Bond ETF, cutting an estimated $1.06M.
  • Wedbush Securities fully exited TAL INTERNATIONAL GROUP, INC. in Q3 2016, selling an estimated $1.44M.
  • Wedbush Securities's ten largest holdings make up 18% of its $671M portfolio in Q3 2016.
  • Wedbush Securities opened 123 new positions and closed 79 in Q3 2016.
  • Wedbush Securities's portfolio value rose 9.9% quarter-over-quarter to $671M.

Based on Wedbush Securities's 13F filing for Q3 2016, filed 4 Nov 2016.